---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-012156"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:58:47.296724+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cingulate FY2023 net loss $23.5M; cash $52k; raised $10.7M in Q1 2024

## Summary
- Net loss widened to $23.5M in 2023 from $17.7M; R&D expense $15.5M (+72% YoY).
- Cash only $52k at year-end; $10.7M raised in Q1 2024 via ATM ($3.2M) and public offering ($7.5M).
- CTx-1301 Phase 3 adult data showed trend vs placebo but not statistically significant; effect size highlighted.
- FDA supports 505(b)(2) path for CTx-2103 (anxiety); IND design agreed.
- Jennifer Callahan promoted to CFO; three independent directors added in Feb 2024.

## SEC filing metadata
- accession: 0001493152-24-012156
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315224012156/0001493152-24-012156-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315224012156/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-012156
- JSON: https://secwatch.observer/filing/0001493152-24-012156.json
- Plain text: https://secwatch.observer/filing/0001493152-24-012156.txt

## Key facts
- Earnings Releases
  Cingulate Inc. reported financial results for the twelve months ended December 31, 2023.
  - Period: the twelve months ended December 31, 2023
  - Result: reported results
  source text: On April 1, 2024, Cingulate Inc. issued a press release announcing its financial results for the year ended December 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315224012156/0001493152-24-012156-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.